Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1

Details for Australian Patent Application No. 2004264722 (hide)

Owner B.M.R.A. Corporation B.V.

Inventors Brunner, Hans R.

Agent Spruson & Ferguson

Pub. Number AU-A-2004264722

PCT Pub. Number WO2005/016334

Priority 60/492,975 07.08.03 US

Filing date 5 August 2004

Wipo publication date 24 February 2005

International Classifications

A61K 31/4035 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/016334 Priority application(s): WO2005/016334

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264724-Piperazine derivatives for the treatment of HIV infections

2004264721-Curved positioning and insertion instrument for inserting a guide wire into the femur